Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MARCH3 |
| Upstream (Parents) |
|---|
| (<<) KLK10 → MARCH3 |
| (<<) BACE2 → MARCH3 |
| (<<) C7orf44 → MARCH3 |
| (<<) C5orf30 → MARCH3 |
| (<<) TGFBI → MARCH3 |
| (<<) SLC2A9 → MARCH3 |
| Downstream (Children) |
|---|
| MARCH3 → PROL1 (>>) |
| MARCH3 → SMO (>>) |
| MARCH3 → FIGF (>>) |
| MARCH3 → SH3TC2 (>>) |
| MARCH3 → TGM2 (>>) |
| MARCH3 → SHPK///TRPV1 (>>) |
| MARCH3 → TNFSF9 (>>) |
| MARCH3 → ACE (>>) |
| MARCH3 → NR4A2 (>>) |
| MARCH3 → CASP10 (>>) |
